成人镰状细胞病患者的听力损失患病率:回顾性队列研究
本研究利用TriNetX数据库回顾性分析2022年门诊就诊的成人,经倾向性评分匹配后比较镰状细胞病与非镰状细胞病队列。镰状细胞病组听力损失发生率更高(6.0% vs. 2.6%),以感音神经性听力损失为主,传导性听力损失无差异。
要点
- 镰状细胞病成人听力损失风险是非镰状细胞病成人的2.4倍。
- 感音神经性听力损失在镰状细胞病组显著更高(OR=2.5)。
- 传导性听力损失发生率两组无显著差异(p=0.238)。
核心结论
- 镰状细胞病与耳鼻咽喉科并发症显著相关,尤其是感音神经性听力损失。
研究设计与样本
- 共识别8,934,438名成人,其中13,870例镰状细胞病患者,经人口学倾向性评分匹配后每组各13,870例,平均年龄40.9岁。
主要发现
- 镰状细胞病组听力损失发生率为6.0%,非镰状细胞病组为2.6%(OR=2.4,95%CI=2.1-2.7,p<0.001)。
- 感音神经性听力损失发生率镰状细胞病组3.2%,非镰状细胞病组1.3%(OR=2.5,95%CI=2.1-3.0,p<0.001)。
- 传导性听力损失发生率两组差异无统计学意义(p=0.238)。
- 镰状细胞病组阻塞性睡眠呼吸暂停(11.9% vs. 6.8%)、过敏性鼻炎(5.9% vs. 3.6%)和鼻窦炎(5.2% vs. 4.5%)发生率更高(均p<0.01)。
临床怎么用
- 建议对镰状细胞病患者进行常规听力评估以减轻听力损失风险。
局限性
- 大型数据库研究中听力报告方式存在局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Sickle cell disease is an inherited hematological disorder characterized by sickle-shaped red blood cells that cause vaso-occlusion and hemolysis. While systemic complications are well described, otolaryngologic manifestations such as hearing loss remain underrecognized despite their impact on quality of life. METHODS: A retrospective study used the TriNetX database to analyze adults (> 18 years) with or without sickle cell disease who had outpatient visits between May 1, 2022, and December 31, 2022. Propensity score matching by demographics was applied. Otolaryngological outcomes were extracted using relevant ICD-10 codes to compare occurrence between sickle cell disease and non-sickle cell disease cohorts. RESULTS: Among 8,934,438 adults identified, 13,870 had sickle cell disease. After matching, each cohort retained 13,870 patients (mean age = 40.9 years). Hearing loss was more likely in the sickle cell disease cohort (6.0% vs. 2.6%; OR = 2.4, 95% CI = 2.1-2.7, p < 0.001). When stratified by hearing loss type, only sensorineural hearing loss was significantly higher (3.2% vs. 1.3%; OR = 2.5, 95% CI = 2.1-3.0, p < 0.001), while conductive hearing loss incidence did not differ (p = 0.238). Other conditions more frequent in sickle cell disease included obstructive sleep apnea (11.9% vs. 6.8%), allergic rhinitis (5.9% vs. 3.6%), and sinusitis (5.2% vs. 4.5%) (all p < 0.01). CONCLUSION: This large, propensity score-matched analysis demonstrated a significant association between sickle cell disease and otolaryngologic complications, particularly sensorineural hearing loss. While there are limitations in how hearing is reported in large database studies, these findings underscore the need for routine hearing assessments to mitigate this risk and improve overall patient care for sickle cell disease patients.
引用
- de Santana Hager M, Brown TD, Sopchak AE, et al. Prevalence of Hearing Loss in Adult Patients With Sickle Cell Disease: A Retrospective Cohort Study. Laryngoscope. 2025. PMID: 41318223. doi:10.1002/lary.70290
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。